Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Camradata Announces Top Asset Class Searches for Investors in March 2018

Published by Gbaf News

Posted on April 13, 2018

4 min read

Last updated: January 21, 2026

Add as preferred source on Google

Graphic depicting Novo Nordisk's Ozempic diabetes drug and NAION eye disease risk - Global Banking & Finance Review — An informative graphic illustrating the link between Novo Nordisk's Ozempic and the increased risk of NAION, a rare eye disease. This image supports the article discussing recent studies and regulatory scrutiny.

CAMRADATA, a leading provider of data and analysis for institutional investors has just released its latest monthly snapshot of the top investment searches carried out in CAMRADATA Live, to keep investors ahead of the latest investment trends.

In the 12 months to 31^st March 2018, just over 21,000 searches were carried out in CAMRADATA Live. 50 products were also added to CAMRADATA Live which focused on several different strategies, including China Equity, Japanese Equity, European Fixed Income, and US Corporate.

In March 2018, the top three most searched asset classes were Global Diversified Growth, Global Equity and US Equity. There was continued interest in Emerging Markets Equity and European Inc. UK Equity, which retained their positions of 4^th and 5^th place respectively since February 2018.

There was growing interest in Global Tactical Asset Allocation, which moved up to 7^th place, from 10^th in the previous month; with Japanese Equities continuing to remain in the top ten of asset classes being searched on.

There were new entrants in the top searched asset managers by AuM, these included Ardevora Asset Management, Fair Oaks Capital, CQS (UK) LLP, LGT Vestra LLP, Old Mutual Global Investors (UK) Limited and MFS Investment Management.

Sean Thompson, Managing Director, CAMRADATA said, “Our latest snapshot of investment searches puts Diversified Growth Funds back in top position after coming second in February. Our latest quarterly investment report showed Diversified Growth Funds have seen a continual growth of the total assets for the past 36 months.

“Global Equities and US Equities were in 2^nd and 3^rd places. This is in line with our quarterly report which showed that 2017 ended positively for the equity markets, with equity markets performing well outside Europe.

“In Europe, while stocks lagged other markets in Q4, economic data remains strong and signs of improving economic growth boosted cyclical stocks. Interest in European Inc. UK Equity continues with this asset class remaining in 5^th place in the search table.

“Our monthly snapshots are essential for keeping clients up-to-date on the latest investment trends, as well as providing them with key insights and data ahead of our more detailed quarterly investment reports.”

CAMRADATA, a leading provider of data and analysis for institutional investors has just released its latest monthly snapshot of the top investment searches carried out in CAMRADATA Live, to keep investors ahead of the latest investment trends.

In the 12 months to 31^st March 2018, just over 21,000 searches were carried out in CAMRADATA Live. 50 products were also added to CAMRADATA Live which focused on several different strategies, including China Equity, Japanese Equity, European Fixed Income, and US Corporate.

In March 2018, the top three most searched asset classes were Global Diversified Growth, Global Equity and US Equity. There was continued interest in Emerging Markets Equity and European Inc. UK Equity, which retained their positions of 4^th and 5^th place respectively since February 2018.

There was growing interest in Global Tactical Asset Allocation, which moved up to 7^th place, from 10^th in the previous month; with Japanese Equities continuing to remain in the top ten of asset classes being searched on.

There were new entrants in the top searched asset managers by AuM, these included Ardevora Asset Management, Fair Oaks Capital, CQS (UK) LLP, LGT Vestra LLP, Old Mutual Global Investors (UK) Limited and MFS Investment Management.

Sean Thompson, Managing Director, CAMRADATA said, “Our latest snapshot of investment searches puts Diversified Growth Funds back in top position after coming second in February. Our latest quarterly investment report showed Diversified Growth Funds have seen a continual growth of the total assets for the past 36 months.

“Global Equities and US Equities were in 2^nd and 3^rd places. This is in line with our quarterly report which showed that 2017 ended positively for the equity markets, with equity markets performing well outside Europe.

“In Europe, while stocks lagged other markets in Q4, economic data remains strong and signs of improving economic growth boosted cyclical stocks. Interest in European Inc. UK Equity continues with this asset class remaining in 5^th place in the search table.

“Our monthly snapshots are essential for keeping clients up-to-date on the latest investment trends, as well as providing them with key insights and data ahead of our more detailed quarterly investment reports.”